今年以来险资频频举牌，尤其在公用事业、银行领域布局明显加快，近期更是少见举牌钢铁业。7月3 日，"湖南钢铁巨头"华菱钢铁（000932）公告称，信泰人寿已通过二级市场集中竞价方式购买该公司股 份至3.45亿股，占公司总股本的比例已达到5%，触及举牌线。险资举牌钢铁企业较为少见。数据显 示，截至2025年第一季度，在46家A股钢铁企业中，仅有15家企业被险资持股，华菱钢铁、抚顺特钢 （600399）、武进不锈（603878）有3家险资持股，其余均仅有1至2家险资持股。(21世纪经济报道) ...

Market Performance - The A-share market continued its strong upward trend, with the Shanghai Composite Index approaching the 3500-point mark, closing at 3472.32 points, reflecting a weekly increase of 1.4% [1] - Over 70% of ETF products achieved positive returns this week, with the Hong Kong innovative drug-related ETFs leading the gains [1][2] ETF Highlights - After a two-week adjustment, Hong Kong innovative drug-related ETFs surged again, with several products, including the Hong Kong Innovative Drug ETF Fund and the Hong Kong Innovative Drug 50 ETF, seeing weekly increases exceeding 7% [5][6] - The median weekly increase for over 1200 ETF products was 1.08%, with only about 200 products experiencing declines [2] - Notably, the steel ETF (515210) saw a significant rise of 5.41%, attributed to Huazhong Steel being targeted by insurance capital [6] Sector Performance - Game-related ETFs also performed well, with several products recording weekly gains of over 6%, driven by substantial increases in constituent stocks such as Kaineng Network and 37 Interactive Entertainment [6] - Conversely, the Hang Seng Technology Index faced a decline of 2.42%, impacting related products, particularly in the internet sector, which saw declines exceeding 3% for several ETFs [8][9] Notable ETF Data - The top-performing Hong Kong innovative drug ETFs included: - Hong Kong Innovative Drug ETF Fund: 7.553% weekly increase - Hong Kong Innovative Drug 50 ETF: 7.483% weekly increase - Hong Kong Innovative Drug ETF ICBC: 7.477% weekly increase [4][5] - The newly established Huabao Hang Seng Hong Kong Innovative Drug Selected ETF (520880) reported that Barclays Bank holds 20 million shares, accounting for 4.5997% of the total fund [6]

Index Performance - The CSI A500 Index increased by 1.32% this week, closing at 4662.51 points on July 4 [4] - The average daily trading volume for the week was 18341.42 billion yuan, with a week-on-week decrease of 9.22% [4] Top Performing Stocks - The top ten stocks with the highest gains this week included: 1. Tian Shou Pharmaceutical (600521.SH) with a gain of 23.34% 2. Daqian Energy (688303.SH) with a gain of 22.18% 3. Junshi Biosciences (688180.SH) with a gain of 18.93% 4. Lepu Medical (300003.SZ) with a gain of 17.99% 5. Giant Network (002558.SZ) with a gain of 17.42% 6. Tongwei Co., Ltd. (600438.SH) with a gain of 17.32% 7. Hualing Steel (000932.SZ) with a gain of 15.37% 8. Pengding Holdings (002938.SZ) with a gain of 14.57% 9. Shenzhou Taiyue (300002.SZ) with a gain of 13.70% 10. Dongshan Precision (002384.SZ) with a gain of 13.36% [3] Underperforming Stocks - The ten stocks with the largest declines this week included: 1. Hengxuan Technology (688608.SH) with a loss of 33.40% 2. Huazhi Shihua (688120.SH) with a loss of 32.34% 3. Northern Huachuang (002371.SZ) with a loss of 22.87% 4. Weining Health (300253.SZ) with a loss of 8.77% 5. China Eastern Airlines (600115.SH) with a loss of 7.07% 6. Xingyuan Material (300568.SZ) with a loss of 6.99% 7. Cambricon Technologies (688256.SH) with a loss of 6.50% 8. Beiyi Innovation (603986.SH) with a loss of 5.93% 9. Jixiang Airlines (603885.SH) with a loss of 5.84% 10. New Zhou Bang (300037.SZ) with a loss of 5.49% [3] Fund Performance - This week, 38 CSI A500 funds collectively rose, with Pu Yin An Sheng leading at a 1.72% increase [5] - The top three funds by size were Huatai-PB (200.88 billion yuan), Guotai (181.5 billion yuan), and GF Fund (174.22 billion yuan) [5] Market Trends - A new trend has emerged in the Hong Kong stock market where A-share listed technology companies are increasingly pursuing secondary listings in Hong Kong [7] - The secondary listings provide diversified financing channels and enhance international market recognition for the companies [7] - The median discount rate for five companies planning secondary listings in Hong Kong is approximately -17% [7] - The core factors driving asset performance are expected to shift from external to internal influences in the second half of the year [7]

Macro & Industry - The "involution" competition in industries such as automotive, photovoltaic, and lithium batteries has intensified, leading to a dilution of profits and a disruption of the industrial ecosystem [1] - The Central Financial Committee emphasized the need to promote a unified national market, focusing on legal governance of low-price competition and encouraging companies to enhance product quality [1] - The Ministry of Industry and Information Technology held a meeting to address low-price competition in the photovoltaic industry and promote the orderly exit of outdated production capacity [1] Company - iPhone sales in China grew by 8% year-on-year in Q2, marking Apple's first sales increase in the region since Q2 2023, driven by promotional activities and improved trade-in values [4][5] - Huawei's sales in Q2 increased by 12%, maintaining its position as the largest company in the Chinese market, followed by Vivo and Apple [5] - Industrial and Commercial Bank of China and other bank stocks reached historical highs, with a sector index increase of nearly 1.7% on July 4, supported by favorable fiscal policies and stable credit growth [5] - Xintai Life Insurance increased its stake in Hualing Steel to 5%, expressing confidence in the company's future and indicating potential for further acquisitions [6] Fund - As of June 30, 136 companies saw stock price increases exceeding 100% this year, with some like United Chemical and Shutai Shen exceeding 400% [7] - Many public funds have invested in high-performing stocks, with notable holdings in companies like Shenghong Technology and Yipin Hong [8] - Fund managers are focusing on sectors such as AI, military industry, industrial metals, and banking for potential investment opportunities in the second half of the year [10]

Regulatory Developments - The National Healthcare Security Administration and the National Health Commission issued measures to support the high-quality development of innovative drugs, encouraging commercial health insurance to expand investment in innovative drugs and establish a directory for innovative drugs covered by commercial health insurance [1] - The Financial Regulatory Bureau reported that the insurance industry achieved a premium income of 3.06 trillion yuan in the first five months of 2025, a year-on-year increase of 3.77% [2] Industry Trends - The Financial Regulatory Bureau is implementing "reporting and execution" in the non-auto insurance sector to eliminate price wars and regulate fees, which is expected to reshape the non-auto insurance market [3] - The insurance industry is facing a pricing challenge, with expected reductions in predetermined interest rates for traditional and participating insurance products, leading companies to adjust product structures and focus on participating insurance [4] - Insurance companies are responding to recent flooding disasters in Guizhou, with over 1,000 claims reported and significant compensation already disbursed [5] Investment Activities - Insurance capital is increasingly entering the A-share market through private equity funds, with major insurers establishing or increasing their private equity fund investments, totaling an estimated 222 billion yuan [6] Corporate Actions - Xintai Life Insurance increased its stake in Hualing Steel, reaching 5% ownership, while Lianan Life Insurance also triggered a stake increase in Jiangnan Water, now holding 5.03% [7] - Sichuan Guobao Life Insurance is undergoing significant changes in ownership and management, with local state-owned assets increasing their stake and a new female leader expected to take charge [8] - Ximei Mutual Life announced the resignation of its chairman, Yang Fan, with Hu Han elected as the new chairman and CEO [9]

Group 1 - Hualing Steel announced that from January 2025 to now, Xintai Life Insurance has cumulatively increased its holdings in the company by 343 million shares, reaching a total of 345 million shares, which accounts for 5.00% of the company's total share capital, triggering the shareholding threshold [1] - Xintai Life's share purchases included 2.71 million shares in January, 10.74 million in February, 122 million in March, 172 million in April, 16.88 million in May, 17.1 million in June, and 690,000 shares in July, with a total value of approximately 1.75 billion yuan at the current share price of 5.1 yuan [1] - Xintai Life expressed optimism about Hualing Steel's future development and recognized the company's value, aiming to support its growth and share in its long-term benefits [1] Group 2 - Hualing Steel's performance has shown a decline, with a revenue of 144.11 billion yuan in 2024, down 12.07% year-on-year, and a net profit attributable to shareholders of 2.03 billion yuan, down 59.99% year-on-year [2] - In the first quarter of this year, the company's revenue continued to decline by 18.52%, reaching 30.08 billion yuan, while the net profit attributable to shareholders increased by 43.55% year-on-year to 562 million yuan [2] - Despite the significant decline in performance, Hualing Steel announced a dividend of 0.1 yuan per share totaling approximately 700 million yuan and plans to repurchase shares worth 200 to 400 million yuan [2]

Group 1 - The core viewpoint of the article emphasizes the significance of the supply-side reform 2.0, which aims to eliminate backward production capacity and effectively address chaotic competition in the industry [1] - The supply-side reform initiated in 2015 led to substantial price increases in commodities, with rebar futures soaring from 843 yuan/ton to 3147 yuan/ton, a 273% increase, and coking coal prices rising from 203 yuan to 719 yuan, a 3.5-fold increase [1] - The recent performance of the steel industry, particularly the China Steel Index, has mirrored past trends, with a notable increase of over 3.5% in a single day, indicating a potential revival similar to the previous supply-side reform [1][4] Group 2 - The current supply-side reform is characterized by unprecedented policy strength, focusing on eliminating low-price competition and orderly phasing out of backward production capacity, suggesting a potential for significant market recovery [6] - The valuation of steel stocks should consider the cyclical nature of the industry, with many steel companies currently valued below their replacement cost by 0.35 times, indicating a sufficient margin of safety [6] - The comparison between the China Steel Index and the National Steel Industry Index shows a high degree of overlap, with both indices focusing on the steel industry, although the China Steel Index includes some coal companies [7] Group 3 - The performance of funds tracking the China Steel Index and the National Steel Industry Index has been similar, with differences in returns being minimal, generally within 0.1% [12] - Specific funds, such as the Guolian National Steel A and Penghua National Steel Industry A, have shown significant returns of 8.10% and 7.66% respectively, outperforming the CSI 300 index [14] - The article suggests that as the economy develops, steel consumption will stabilize, with a shift from rebar consumption in construction to sheet metal consumption in manufacturing, indicating a potential improvement in profitability for the steel sector [14]

Core Viewpoint - The steel sector is experiencing a rally despite overall market fluctuations, driven by environmental regulations and improving demand conditions [1][3]. Group 1: Market Performance - The steel ETF (515210) rose by 1.67%, leading the market with a trading volume of nearly 104 million yuan [1]. - Key holdings such as Lingang Co. and Liugang Co. have seen consecutive trading limits, while other stocks like Shougang Co. and Hesteel Co. increased by nearly 5% [1]. - Since September 2, 2024, the steel ETF has gained 31.33%, outperforming the Shanghai Composite Index [6]. Group 2: Supply and Demand Dynamics - Tangshan has intensified its environmental production restrictions, with rumors of measures from July 4 to July 15 [3]. - The China Iron and Steel Association is set to hold a meeting, although the agenda remains undisclosed [3]. - Steel inventory among key enterprises increased by 420,000 tons to 16.21 million tons in mid-June, but decreased by 140,000 tons compared to the same period last month [3]. Group 3: Industry Outlook - The operating rate of H-beam steel producers rose by 3.23 percentage points to 70.97%, with capacity utilization increasing by 0.9 percentage points to 56.83% [4]. - Demand is expected to improve marginally due to supportive real estate policies and stable infrastructure investment, while supply constraints are becoming more pronounced [4]. - The profit margin for the black metal smelting and rolling industry reached 31.69 billion yuan in the first five months of 2025, marking a return to profitability year-on-year [4]. - The comprehensive gross profit for the steel industry was 281 yuan per ton in the first half of 2025, reflecting a year-on-year increase of 52.45% [4].

Group 1 - Insurance capital has been actively increasing stakes in companies, with 15 companies being targeted and 19 instances of stake increases in 2023, nearly matching the total of 20 from the previous year [1] - On July 3, Xintai Life Insurance acquired 3.45 million shares of Hualing Steel, representing 5% of the company's total equity, with a trading average price of 4.84 yuan per share [1] - Xintai Life expressed confidence in Hualing Steel's future and aims to enhance its influence and share in the company's long-term growth [1] Group 2 - Lianan Life Insurance increased its stake in Jiangnan Water by acquiring 1.1 million shares, raising its total holdings to 46.9954 million shares, or 5.03% of the total equity [2] - The stake increase by Lianan Life is based on its own asset allocation needs and the perceived value of Jiangnan Water, with funding sourced from its own capital [2] - Jiangnan Water's control remains unchanged, with the actual controlling shareholders being Jiangyin Public Asset Management Co. and Jiangyin Public Utilities Group Co. [2] Group 3 - Changcheng Life Insurance previously acquired a stake in Jiangnan Water, reaching 5.0001% in May of the previous year, indicating a trend of insurance companies increasing their stakes based on long-term investment strategies [3] - In June, Changcheng Life also announced the acquisition of 4.4 million shares of Qindao Port, increasing its total holdings to 279.4 million shares, or 5.0005% of the total equity [4] - Ping An Life has also been active, increasing its stake in China Merchants Bank to 15% through multiple transactions, reflecting a sustained interest in the bank's long-term investment value [4]

Group 1 - The steel sector experienced a strong rally on July 4, with notable stock performances including Lingang Co. hitting the daily limit, Liugang Co. achieving four consecutive limit-ups, and Angang Steel rising over 6% [1] - Liugang Co. has not identified any media reports or market rumors that could impact its stock price, and its fundamentals remain unchanged, with major shareholders holding 83.01% of the company [1] - The Central Financial Committee emphasized the need to promote the orderly exit of outdated production capacity and improve product quality, which may positively influence the steel sector's profitability [2] Group 2 - There are reports of increased environmental restrictions and production cuts in Tangshan, with approximately half of the steel mills indicating they have received notifications regarding these measures [1] - The steel sector's profitability is expected to recover to historical average levels, and the price-to-book ratio (PB) of steel stocks may also improve as a result [2]